蛋白抑制剂-话题@MedSci

#蛋白抑制剂#

17篇内容 | 663人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1934299, encodeId=958c193429949, content=<a href='/topic/show?id=dab18865241' target=_blank style='color:#2F92EE;'>#蛋白抑制剂#</a>, objectTitle=新一代心肌肌球蛋白抑制剂aficamten在中国获得3期临床试验申请批准，用于治疗症状性梗阻性肥厚型心肌病, objectType=article, longId=730815, objectId=f09be30815b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f09be30815b3, replyNumber=0, likeNumber=36, createdTime=2023-04-14, rootId=0, userName=xsm918, userId=49cf452, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f09be30815b3, moduleTitle=新一代心肌肌球蛋白抑制剂aficamten在中国获得3期临床试验申请批准，用于治疗症状性梗阻性肥厚型心肌病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f09be30815b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934298, encodeId=6ce41934298c6, content=<a href='/topic/show?id=dab18865241' target=_blank style='color:#2F92EE;'>#蛋白抑制剂#</a>, objectTitle=EBioMedicine ：CBP/β-连环蛋白抑制剂PRI-724在丙型和乙型肝炎病毒诱导的肝硬化患者中的安全性、耐受性和抗纤维化效果, objectType=article, longId=727868, objectId=a22fe2786820, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a22fe2786820, replyNumber=0, likeNumber=29, createdTime=2022-06-29, rootId=0, userName=xsm918, userId=49cf452, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a22fe2786820, moduleTitle=EBioMedicine ：CBP/β-连环蛋白抑制剂PRI-724在丙型和乙型肝炎病毒诱导的肝硬化患者中的安全性、耐受性和抗纤维化效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a22fe2786820)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934296, encodeId=90c91934296a7, content=<a href='/topic/show?id=dab18865241' target=_blank style='color:#2F92EE;'>#蛋白抑制剂#</a>, objectTitle=Nat Commun：淀粉样蛋白抑制剂可以恢复p53突变体的肿瘤抑制功能 , objectType=article, longId=213730, objectId=ab39213e3061, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab39213e3061, replyNumber=0, likeNumber=27, createdTime=2022-05-06, rootId=0, userName=xsm918, userId=49cf452, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab39213e3061, moduleTitle=Nat Commun：淀粉样蛋白抑制剂可以恢复p53突变体的肿瘤抑制功能 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab39213e3061)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934297, encodeId=4a32193429e79, content=<a href='/topic/show?id=dab18865241' target=_blank style='color:#2F92EE;'>#蛋白抑制剂#</a>, objectTitle=JAHA：钠-葡萄糖协同转运蛋白抑制剂与房颤, objectType=article, longId=216436, objectId=88d621643623, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88d621643623, replyNumber=0, likeNumber=31, createdTime=2022-06-01, rootId=0, userName=xsm918, userId=49cf452, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88d621643623, moduleTitle=JAHA：钠-葡萄糖协同转运蛋白抑制剂与房颤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88d621643623)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934295, encodeId=1157193429599, content=<a href='/topic/show?id=dab18865241' target=_blank style='color:#2F92EE;'>#蛋白抑制剂#</a>, objectTitle=Cell Res：迷惑新冠病毒，西湖大学/复旦大学合作设计出新冠蛋白抑制剂, objectType=article, longId=203589, objectId=6f40203589bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f40203589bd, replyNumber=0, likeNumber=0, createdTime=2021-04-16, rootId=0, userName=xsm918, userId=49cf452, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f40203589bd, moduleTitle=Cell Res：迷惑新冠病毒，西湖大学/复旦大学合作设计出新冠蛋白抑制剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f40203589bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934294, encodeId=ca151934294a4, content=<a href='/topic/show?id=dab18865241' target=_blank style='color:#2F92EE;'>#蛋白抑制剂#</a>, objectTitle=Lancet：心肌肌球蛋白抑制剂Mavacamten治疗梗阻性肥厚型心肌病！, objectType=article, longId=200122, objectId=01d820012261, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01d820012261, replyNumber=0, likeNumber=29, createdTime=2021-03-18, rootId=0, userName=xsm918, userId=49cf452, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01d820012261, moduleTitle=Lancet：心肌肌球蛋白抑制剂Mavacamten治疗梗阻性肥厚型心肌病！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=01d820012261)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934292, encodeId=f7cc1934292a7, content=<a href='/topic/show?id=dab18865241' target=_blank style='color:#2F92EE;'>#蛋白抑制剂#</a>, objectTitle=Cell:首次发现针对III型CRISPR-Cas系统的蛋白抑制剂, objectType=article, longId=180679, objectId=2b5d1806e9cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b5d1806e9cc, replyNumber=0, likeNumber=26, createdTime=2020-06-09, rootId=0, userName=xsm918, userId=49cf452, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b5d1806e9cc, moduleTitle=Cell:首次发现针对III型CRISPR-Cas系统的蛋白抑制剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b5d1806e9cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934290, encodeId=3f351934290b0, content=<a href='/topic/show?id=dab18865241' target=_blank style='color:#2F92EE;'>#蛋白抑制剂#</a>, objectTitle=赛诺菲/Lexicon的钠依赖性葡萄糖共转运蛋白抑制剂Zynquista，在欧盟获批用于治疗I型糖尿病, objectType=article, longId=165297, objectId=b27a16529e79, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b27a16529e79, replyNumber=0, likeNumber=37, createdTime=2019-11-07, rootId=0, userName=xsm918, userId=49cf452, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b27a16529e79, moduleTitle=赛诺菲/Lexicon的钠依赖性葡萄糖共转运蛋白抑制剂Zynquista，在欧盟获批用于治疗I型糖尿病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b27a16529e79)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934293, encodeId=cc19193429330, content=<a href='/topic/show?id=dab18865241' target=_blank style='color:#2F92EE;'>#蛋白抑制剂#</a>, objectTitle=Lancet Gastroen Hepatol：HBV核心蛋白抑制剂ABI-H0731临床研究数据喜人, objectType=article, longId=182839, objectId=a1dc18283966, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1dc18283966, replyNumber=0, likeNumber=30, createdTime=2020-02-09, rootId=0, userName=xsm918, userId=49cf452, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1dc18283966, moduleTitle=Lancet Gastroen Hepatol：HBV核心蛋白抑制剂ABI-H0731临床研究数据喜人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1dc18283966)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934291, encodeId=089319342917e, content=<a href='/topic/show?id=dab18865241' target=_blank style='color:#2F92EE;'>#蛋白抑制剂#</a>, objectTitle=2019 ASCO：AbbVie/Roche发表其BCL-2蛋白抑制剂Venclyxto治疗白血病的阳性数据, objectType=article, longId=167754, objectId=98e616e75482, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98e616e75482, replyNumber=0, likeNumber=31, createdTime=2019-12-17, rootId=0, userName=xsm918, userId=49cf452, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98e616e75482, moduleTitle=2019 ASCO：AbbVie/Roche发表其BCL-2蛋白抑制剂Venclyxto治疗白血病的阳性数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=98e616e75482)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934289, encodeId=ee731934289dd, content=<a href='/topic/show?id=dab18865241' target=_blank style='color:#2F92EE;'>#蛋白抑制剂#</a>, objectTitle=Gastroenterology：NS5A蛋白抑制剂对HCV基因1-7型的作用以及对逃逸变异的影响, objectType=article, longId=124775, objectId=b85a124e7526, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b85a124e7526, replyNumber=0, likeNumber=24, createdTime=2018-03-03, rootId=0, userName=xsm918, userId=49cf452, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b85a124e7526, moduleTitle=Gastroenterology：NS5A蛋白抑制剂对HCV基因1-7型的作用以及对逃逸变异的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b85a124e7526)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934288, encodeId=e764193428816, content=<a href='/topic/show?id=dab18865241' target=_blank style='color:#2F92EE;'>#蛋白抑制剂#</a>, objectTitle=中国肾移植受者哺乳动物雷帕霉素靶蛋白抑制剂临床应用专家共识, objectType=article, longId=115429, objectId=5bfd11542946, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5bfd11542946, replyNumber=0, likeNumber=22, createdTime=2018-06-02, rootId=0, userName=xsm918, userId=49cf452, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5bfd11542946, moduleTitle=中国肾移植受者哺乳动物雷帕霉素靶蛋白抑制剂临床应用专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5bfd11542946)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934286, encodeId=d6c71934286b1, content=<a href='/topic/show?id=dab18865241' target=_blank style='color:#2F92EE;'>#蛋白抑制剂#</a>, objectTitle=LANCET：回肠胆汁酸转运蛋白抑制剂GSK2330672对原发性胆汁性胆管炎瘙痒症状疗效的研究, objectType=article, longId=88921, objectId=661688921f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=661688921f8, replyNumber=0, likeNumber=40, createdTime=2017-11-22, rootId=0, userName=xsm918, userId=49cf452, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=661688921f8, moduleTitle=LANCET：回肠胆汁酸转运蛋白抑制剂GSK2330672对原发性胆汁性胆管炎瘙痒症状疗效的研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=661688921f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934287, encodeId=3cb3193428edd, content=<a href='/topic/show?id=dab18865241' target=_blank style='color:#2F92EE;'>#蛋白抑制剂#</a>, objectTitle=Chem Commun：北生所张志远与王晓东实验室合作研发了新型MLKL蛋白抑制剂, objectType=article, longId=96570, objectId=e826965e087, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e826965e087, replyNumber=0, likeNumber=29, createdTime=2017-11-25, rootId=0, userName=xsm918, userId=49cf452, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e826965e087, moduleTitle=Chem Commun：北生所张志远与王晓东实验室合作研发了新型MLKL蛋白抑制剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e826965e087)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934285, encodeId=e24319342855d, content=<a href='/topic/show?id=dab18865241' target=_blank style='color:#2F92EE;'>#蛋白抑制剂#</a>, objectTitle=Cancer Res：科学家发现热激蛋白抑制剂或可用于癌症治疗, objectType=article, longId=60688, objectId=1b036068884, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b036068884, replyNumber=0, likeNumber=27, createdTime=2016-10-06, rootId=0, userName=xsm918, userId=49cf452, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b036068884, moduleTitle=Cancer Res：科学家发现热激蛋白抑制剂或可用于癌症治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b036068884)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934284, encodeId=18e71934284ad, content=<a href='/topic/show?id=dab18865241' target=_blank style='color:#2F92EE;'>#蛋白抑制剂#</a>, objectTitle=PNAS：极难治乳腺癌觅良方？蛋白抑制剂为化疗开路, objectType=article, longId=43881, objectId=b3c94388194, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3c94388194, replyNumber=0, likeNumber=31, createdTime=2015-01-25, rootId=0, userName=xsm918, userId=49cf452, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3c94388194, moduleTitle=PNAS：极难治乳腺癌觅良方？蛋白抑制剂为化疗开路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3c94388194)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1934283, encodeId=727919342832e, content=<a href='/topic/show?id=dab18865241' target=_blank style='color:#2F92EE;'>#蛋白抑制剂#</a>, objectTitle=JCI：蛋白抑制剂治疗颅骨和皮肤出生缺陷, objectType=article, longId=6307, objectId=a25c630e6d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a25c630e6d, replyNumber=0, likeNumber=41, createdTime=2012-08-31, rootId=0, userName=xsm918, userId=49cf452, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a25c630e6d, moduleTitle=JCI：蛋白抑制剂治疗颅骨和皮肤出生缺陷, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a25c630e6d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

蛋白抑制剂

2020-05-29

xsm918 (审核中...)

前往app查看评论内容

#蛋白抑制剂#

新一代心肌肌球蛋白抑制剂aficamten在中国获得3期临床试验申请批准，用于治疗症状性梗阻性肥厚型心肌病

2023-04-14

xsm918 (审核中...)

前往app查看评论内容

#蛋白抑制剂#

EBioMedicine ：CBP/β-连环蛋白抑制剂PRI-724在丙型和乙型肝炎病毒诱导的肝硬化患者中的安全性、耐受性和抗纤维化效果

2022-06-29

xsm918 (审核中...)

前往app查看评论内容

#蛋白抑制剂#

Nat Commun：淀粉样蛋白抑制剂可以恢复p53突变体的肿瘤抑制功能

2022-05-06

xsm918 (审核中...)

前往app查看评论内容

#蛋白抑制剂#

JAHA：钠-葡萄糖协同转运蛋白抑制剂与房颤

2022-06-01

xsm918 (审核中...)

前往app查看评论内容

#蛋白抑制剂#

Cell Res：迷惑新冠病毒，西湖大学/复旦大学合作设计出新冠蛋白抑制剂

2021-04-16

xsm918 (审核中...)

前往app查看评论内容

#蛋白抑制剂#

Lancet：心肌肌球蛋白抑制剂Mavacamten治疗梗阻性肥厚型心肌病！

2021-03-18

xsm918 (审核中...)

前往app查看评论内容

#蛋白抑制剂#

Cell:首次发现针对III型CRISPR-Cas系统的蛋白抑制剂

2020-06-09

xsm918 (审核中...)

前往app查看评论内容

#蛋白抑制剂#

赛诺菲/Lexicon的钠依赖性葡萄糖共转运蛋白抑制剂Zynquista，在欧盟获批用于治疗I型糖尿病

2019-11-07

xsm918 (审核中...)

前往app查看评论内容

#蛋白抑制剂#

Lancet Gastroen Hepatol：HBV核心蛋白抑制剂ABI-H0731临床研究数据喜人

2020-02-09

xsm918 (审核中...)

前往app查看评论内容

#蛋白抑制剂#

2019 ASCO：AbbVie/Roche发表其BCL-2蛋白抑制剂Venclyxto治疗白血病的阳性数据

2019-12-17

xsm918 (审核中...)

前往app查看评论内容

#蛋白抑制剂#

Gastroenterology：NS5A蛋白抑制剂对HCV基因1-7型的作用以及对逃逸变异的影响

2018-03-03

xsm918 (审核中...)

前往app查看评论内容

#蛋白抑制剂#

中国肾移植受者哺乳动物雷帕霉素靶蛋白抑制剂临床应用专家共识

2018-06-02

xsm918 (审核中...)

前往app查看评论内容

#蛋白抑制剂#

LANCET：回肠胆汁酸转运蛋白抑制剂GSK2330672对原发性胆汁性胆管炎瘙痒症状疗效的研究

2017-11-22

xsm918 (审核中...)

前往app查看评论内容

#蛋白抑制剂#

Chem Commun：北生所张志远与王晓东实验室合作研发了新型MLKL蛋白抑制剂

2017-11-25

xsm918 (审核中...)

前往app查看评论内容

#蛋白抑制剂#

Cancer Res：科学家发现热激蛋白抑制剂或可用于癌症治疗

2016-10-06

xsm918 (审核中...)

前往app查看评论内容

#蛋白抑制剂#

PNAS：极难治乳腺癌觅良方？蛋白抑制剂为化疗开路

2015-01-25

xsm918 (审核中...)

前往app查看评论内容

#蛋白抑制剂#

JCI：蛋白抑制剂治疗颅骨和皮肤出生缺陷

2012-08-31

科室
- - 订阅+
  - 更多科室
工具
服务